News & Views

  • New Partnership with German Based Company

New Partnership with German Based Company

Aug 25 2009 Read 1416 Times

BioFocus DPI a provider of gene-to-candidate discovery services are partnering with German-based biotech TET Systems Holding to apply its inducible gene technology in high-throughput drug discovery screening
campaigns performed for BioFocus DPI’s customers. This approach enables control of individual genes both quantitatively and reversibly in cellular assays and is particularly powerful in cases where the target is not
well tolerated in the cells, since the protein will not be expressed until required for screening. “The TET Technology allows us to build on the proven compound screening service that we offer clients. This powerful approach will benefit discovery programmes that are hindered by difficult to express targets. Using this technology, we will be able to perform more efficient, extensive compound screening on these problematic targets,” commented Dr. Kate Hilyard, VP Biological Sciences, BioFocus DPI.

“We are very pleased to sign this agreement with BioFocus DPI, one of the leading drug discovery service providers worldwide. TET Technology has been used successfully for many years by most of the major
pharmaceutical companies. Through this new partnership with BioFocus DPI, a broader range of pharmaceutical and biotechnology companies will gain access to TET System’s gene expression technology,” stated Dr Ernst Boehnlein, CEO of TET Systems Holding and IP Merchandisers.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

Lab Asia December 2019

December 2019

In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...

View all digital editions

Events

SLAS 2020

Jan 25 2020 San Diego, CA, USA

Arab Health

Jan 27 2020 Dubai, UAE

Nano Tech 2020

Jan 29 2020 Tokyo, Japan

HTC-16

Jan 29 2020 Ghent, Belgium

MEDLAB MIDDLE EAST

Feb 03 2020 Dubai, UAE

View all events